FDA Device Intelligence
HomeAROA BIOSURGERY LIMITED › Restella

Restella

AROA BIOSURGERY LIMITED · Model R20243-1122P · UDI-DI 09421904065994

FTMFTL Prescription
10
510(k) clearances
11,622
Adverse events (48 deaths)
76
Recalls
89
Facilities

Description

Restella™ is for implantation to reinforce soft tissue where weakness exists in patients requiring soft tissue repair or reinforcement in plastic and reconstructive surgery. The device is supplied sterile and is intended for one-time use.

Recalls

DateFirmReason
2024-08-07Cook Biotech, Inc.Products expire prior to the expiration date printed on the product labeling
2024-08-07Cook Biotech, Inc.Products expire prior to the expiration date printed on the product labeling
2024-08-07Cook Biotech, Inc.Products expire prior to the expiration date printed on the product labeling
2024-08-07Cook Biotech, Inc.Products expire prior to the expiration date printed on the product labeling
2024-08-07Cook Biotech, Inc.Products expire prior to the expiration date printed on the product labeling
2024-08-07Cook Biotech, Inc.Products expire prior to the expiration date printed on the product labeling
2024-08-07Cook Biotech, Inc.Products expire prior to the expiration date printed on the product labeling
2024-08-07Cook Biotech, Inc.Products expire prior to the expiration date printed on the product labeling
2024-08-07Cook Biotech, Inc.Products expire prior to the expiration date printed on the product labeling
2024-08-07Cook Biotech, Inc.Products expire prior to the expiration date printed on the product labeling

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.